Aditx Therapeutics Inc (ADTX)

Currency in USD
1.0400
+0.0100(+0.97%)
Closed·
1.0500+0.0100(+0.96%)
·
ADTX Scorecard
Full Analysis
Analysts anticipate sales growth in the current year
ADTX is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
1.01001.0700
52 wk Range
0.81009,399.0000
Key Statistics
Prev. Close
1.03
Open
1.02
Day's Range
1.01-1.07
52 wk Range
0.81-9,399
Volume
135.86K
Average Volume (3m)
840.06K
1-Year Change
-99.99%
Book Value / Share
5.33
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
ADTX Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Suffers from weak gross profit margins

Aditx Therapeutics Inc News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Buy

Aditx Therapeutics Inc Company Profile

Aditxt, Inc., a commercial-stage company, discovers and develops products in the areas of immune health, precision health, population health, women’s health, and neurologic health. The company develops AditxtScore that enable individuals to understand, manage, and monitor their immune profiles in order to be informed about attacks on or by their immune system; and Apoptotic DNA Immunotherapy, a nucleic acid-based technology that utilizes an approach that mimics the way the body naturally induces tolerance to its tissues. It also develops ADI-100 for skin grafting, psoriasis, type 1 diabetes, and multiple sclerosis. Aditxt, Inc. has a license agreement with Loma Linda University and Leland Stanford Junior University. The company was formerly known as ADiTx Therapeutics, Inc. and changed its name to Aditxt, Inc. in July 2021. Aditxt, Inc. was incorporated in 2017 and is headquartered in Mountain View, California.

Compare ADTX to Peers and Sector

Metrics to compare
ADTX
Peers
Sector
Relationship
P/E Ratio
−0.2x−3.2x−0.6x
PEG Ratio
-−0.010.00
Price/Book
0.4x1.2x2.6x
Price / LTM Sales
429.5x33.5x3.3x
Upside (Analyst Target)
-238.4%38.0%
Fair Value Upside
Unlock−3.2%4.4%Unlock

Earnings

Latest Release
Aug 14, 2025
EPS / Forecast
-3.45 / --
Revenue / Forecast
1.00K / --
EPS Revisions
Last 90 days

ADTX Income Statement

People Also Watch

53.49
BMNR
+12.07%
4.490
ONDS
+18.16%
19.550
ZETA
+6.89%
16.80
OSCR
+8.95%
0.486
PSTV
+0.62%

FAQ

What Stock Exchange Does Aditx Trade On?

Aditx is listed and trades on the Nasdaq Stock Exchange stock exchange.

What Is the Stock Symbol for Aditx?

The stock symbol for Aditx is "ADTX."

What Is the Aditx Market Cap?

As of today, Aditx market cap is 5.20M.

What Is Aditx's Earnings Per Share (TTM)?

The Aditx EPS (TTM) is -43.53.

From a Technical Analysis Perspective, Is ADTX a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has Aditx Stock Split?

Aditx has split 4 times.

How Many Employees Does Aditx Have?

Aditx has 26 employees.

What is the current trading status of Aditx (ADTX)?

As of 24 Aug 2025, Aditx (ADTX) is trading at a price of 1.04, with a previous close of 1.03. The stock has fluctuated within a day range of 1.01 to 1.07, while its 52-week range spans from 0.81 to 9,399.00.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.